Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02286765 · ClinicalTrials.gov registry record · NA
Ulthera® System for Treating Axillary Hyperhidrosis
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02286765 is a NA study that has completed, run by Ulthera. The registered enrollment target is 40 participants.
The verdict
NCT02286765, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Up to 20 enrolled subjects will be treated. Subjects will receive two Ulthera® treatments on the axillas provided 30 days apart. Follow-up visits will occur at 7, 30, 90 and 180 days following the last treatment. Protocol amendment: The study was expanded to enroll an additional 20 subjects into Group A.
Interventions
- DEVICE Ulthera System treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02286765
The ClinicalTrials.gov registry entry for NCT02286765 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulthera System treatment is the first listed.
NCT02286765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02286765 about?
NCT02286765 is a clinical study titled "Ulthera® System for Treating Axillary Hyperhidrosis". Up to 20 enrolled subjects will be treated. Subjects will receive two Ulthera® treatments on the axillas provided 30 days apart. Follow-up visits will occur at 7, 30, 90 and 180 days following the last treatment. Protocol amendment: The study was expanded to enroll an additional 20 subjects into Gr...
What is the current status of trial NCT02286765?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-10. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02286765?
The interventions under investigation include: Ulthera System treatment (DEVICE).
Who is sponsoring clinical trial NCT02286765?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.